Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy

Irene Lara-Corrales, Anna L. Bruckner, Julio Cesar Salas Alanis, Jemma E. Mellerio, Francis Pallison, Dédée F. Murrell

Resultado de la investigación

2 Citas (Scopus)

Resumen

© Springer-Verlag Berlin Heidelberg 2015. There have been many comorbidities identified in EB patients; the most commonly seen are anemia, infections, osteopenia, failure to thrive, renal disease, squamous cell carcinoma, and cardiomyopathy. Physicians caring for EB patients should be aware of all these complications, initially to prevent some of these from developing by establishing preventive measures and secondly to monitor closely and identify early signs and symptoms of these complications for better clinical outcomes.
Idioma originalEnglish
Título de la publicación alojadaBlistering Diseases: Clinical Features, Pathogenesis, Treatment
Número de páginas19
ISBN (versión digital)9783662456989
DOI
EstadoPublished - 1 ene 2015
Publicado de forma externa

Huella Profundice en los temas de investigación de 'Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy'. En conjunto forman una huella única.

  • Citar esto

    Lara-Corrales, I., Bruckner, A. L., Salas Alanis, J. C., Mellerio, J. E., Pallison, F., & Murrell, D. F. (2015). Monitoring to Prevent Complications: Anemia, Infections, Osteopenia, Failure to Thrive, Renal Disease, Squamous Cell Carcinoma, Cardiomyopathy. En Blistering Diseases: Clinical Features, Pathogenesis, Treatment https://doi.org/10.1007/978-3-662-45698-9_71